about
Plasma interleukin 8 concentrations in obese subjects with impaired glucose tolerancePlasma levels of soluble tumor necrosis factor-alpha receptors are related to total and LDL-cholesterol in lean, but not in obese subjects.Circulating brain-derived neurotrophic factor concentration is downregulated by intralipid/heparin infusion or high-fat meal in young healthy male subjects.Relationship Between Serum IL-12 and p40 Subunit Concentrations and Lipid Parameters in Overweight and Obese Women.Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.Insulin sensitivity, metabolic flexibility, and serum adiponectin concentration in women with anorexia nervosa.Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation.Normal metabolic flexibility despite insulin resistance women with polycystic ovary syndrome.Insulin resistance and fasting plasma glucose in first degree relatives of patients with type 1 diabetes.An alternative spliced variant of circulating soluble tumor necrosis factor-alpha receptor-2 is paradoxically associated with insulin action.Adipose tissue, but not skeletal muscle, sirtuin 1 expression is decreased in obesity and related to insulin sensitivity.Prognostic markers for the development of type 1 diabetes in first-degree relatives of diabetic patients.Wnt Signaling Genes in Adipose Tissue and Skeletal Muscle of Humans With Different Degrees of Insulin Sensitivity.Ceramide metabolism is affected by obesity and diabetes in human adipose tissueDecreased serum brain-derived neurotrophic factor concentration in young nonobese subjects with low insulin sensitivitySerum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitusThe effect of moderate weight loss, with or without (1, 3)(1, 6)-β-glucan addition, on subcutaneous adipose tissue inflammatory gene expression in young subjects with uncomplicated obesity
P50
Q24803201-3637271C-61FD-46DD-9948-958583A03E2CQ34882920-2B37CA34-7A29-406A-A3CD-9F227A386D22Q40590365-41E46F03-0FAF-4D15-9590-BB8DC85138ABQ40874119-F67E391C-BFCD-4BC3-AF4F-7A0D6334DE99Q42517198-8233986E-3301-450C-BA12-81DFFC6E53C6Q43257384-959BD3EA-DFA5-47FE-88D3-EE5BAFB167EDQ44291981-FEB492A4-FB74-4FCC-9023-9EFCF9BA7991Q44643211-888AD11E-105F-4A21-951C-716BB1AC4AC8Q47925609-E3FA2DBB-0FD1-4501-93A9-00C309C4A090Q48090229-90E0D76C-FEFF-49AE-BD2B-52BB4D07C3E9Q50126025-98C39F21-262E-4725-80CE-8CD61D3ADC82Q51320004-BCC8EC64-4ACB-4BC4-B7B2-A9AAAE5C71C6Q53784291-16DE7841-07EC-4733-B88F-383C05859122Q83711035-40F1BDB3-DD24-4A9F-ABE6-8C98002E64E6Q84213114-9614F28F-6BA9-4B03-9BB6-A66AB6E86AB3Q87430757-39190E86-F1F6-446C-BB66-19D3001E2D6FQ88601340-897E2A23-8723-484E-B199-69A106CCF3FA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Agnieszka Nikolajuk
@ast
Agnieszka Nikolajuk
@en
Agnieszka Nikolajuk
@es
Agnieszka Nikolajuk
@nl
type
label
Agnieszka Nikolajuk
@ast
Agnieszka Nikolajuk
@en
Agnieszka Nikolajuk
@es
Agnieszka Nikolajuk
@nl
prefLabel
Agnieszka Nikolajuk
@ast
Agnieszka Nikolajuk
@en
Agnieszka Nikolajuk
@es
Agnieszka Nikolajuk
@nl
P106
P1153
6506851394
P31
P496
0000-0001-9734-5221